Cystic renal neoplasms and renal epithelial stromal tumors are diagnostically challenging and represent some novel tumor entities. In this article, clinical and pathologic features of established and novel entities are discussed. Predominantly cystic renal tumors include cystic nephroma/mixed epithelial and stromal tumor, synovial sarcoma, and multilocular cystic renal cell carcinoma. These entities are own tumor entities of the 2004 WHO classification of renal tumors. Tubulocystic carcinoma and acquired cystic disease-associated renal cell carcinoma are neoplasms with an intrinsically cystic growth pattern. Both tumor types should be included in a future WHO classification as novel entities owing to their characteristic features. Cysts and clear cell renal cell carcinoma frequently coexist within the kidneys of patients with von Hippel-Lindau disease. Sporadic clear cell renal cell carcinomas often contain cysts, usually as a minor component. Some clear cell renal cell carcinomas have prominent cysts, and multilocular cystic renal cell carcinoma is composed almost exclusively of cysts. Recent molecular findings suggest that clear cell renal cancer may develop through cyst-dependent and cystindependent molecular pathways. (Adv Anat Pathol 2010;17:209-214) FIGURE 1. Mixed epithelial and stromal tumor/cystic nephroma with dominant cystic growth.
K idney cysts are related to developmental, acquired, and neoplastic lesions. Nonneoplastic cystic or cavitary lesions are simple cysts, traumatic cysts, infectious cysts, an aneurism or a varix. Developmental abnormalities include cystic dysplasia and polycystic kidney disease. Cystic renal tumors are not classified as a separate pathologic entity, but many renal neoplasms contain cysts as a minor or dominant component. Papillary renal cell carcinoma (especially type 1) can present as a large cyst containing hemorrhagic fluid or necrotic material surrounded by a thick pseudocapsule. There are angiomyolipoma with epithelial cysts 1 and oncocytoma with prominent cysts. 2 Cystic change occurs in up to 15% of clear-cell renal cell carcinoma (ccRCC). Some ccRCC have a dominant cystic component; some arise in a simple cyst whereas multilocular cystic renal cell carcinoma is composed exclusively of cysts. In addition to these findings, there are uncommon renal neoplasms with cysts as a characteristic finding at gross examination. In adults, renal tumor entities with characteristic cysts include:
Cystic nephroma/mixed epithelial and stromal tumor Tubulocystic carcinoma Synovial sarcoma (''Cystic embryonal sarcoma'') Acquired cystic disease-associated renal cell carcinoma Clear cell renal cell carcinoma with prominent cysts Multilocular cystic renal cell carcinoma There is some controversy concerning pathogenesis and classification of these neoplasms. The aim of this article is to summarize the present knowledge of these tumors and to address a recent molecular concept of a cyst-dependent and cyst-independent signaling pathway in the development of ccRCC.
MIXED EPITHELIAL AND STROMAL TUMOR/ CYSTIC NEPHROMA
In 1993, Pawade et al 3 described three cases of a novel cystic renal tumor which they termed ''cystic hamartoma of the renal pelvis.'' Additional cases have been reported as ''mesoblastic nephroma of adults'' and as ''mixed epithelial and stromal tumor of the kidney.'' [4] [5] [6] [7] The last terminology is preferred because these tumors clearly have no relationship to mesoblastic nephroma of infants and as they appear to be mixtures of neoplastic epithelial components and spindle cells. There is a strong predominance of women, often of perimenopausal age.
Most of these tumors appear to arise centrally in the kidney and to grow as expansile masses (Fig. 1) . The tumors lack a thick fibrous wall but compressed renal tissue usually forms a pseudocapsule in the larger tumors. The tumors are grossly composed of multiple cysts and solid areas. The solid areas may be extensive (Fig. 2 ). The septa of the cysts are thicker than is typical of cystic nephroma, cystic partially differentiated nephroblastoma, and multilocular cystic clear cell renal cell carcinoma. These are complex tumors composed of large cysts, microcysts, and tubules. The largest cysts are lined by columnar and cuboidal epithelium that sometimes forms small papillary tufts. The microcysts and tubules are lined by flattened, cuboidal, or columnar cells (Fig. 3 ). The stroma consists of a variably cellular population of spindle cells with plump nuclei and abundant cytoplasm (''ovarian-type stroma''). Areas of myxoid stroma and fascicles of smooth muscle cells may be prominent. Blood vessels with thick walls may be present. Fat cells may be present. Mitotic figures and atypical nuclei have not been reported. The relationship between cystic nephroma and mixed epithelial and stromal tumor of the kidney has been controversially discussed. Recently, the term renal epithelial and stromal tumor (REST) has been proposed as a unifying term of cystic nephroma and mixed epithelial and stromal tumor. 8, 9 TUBULOCYSTIC RENAL CELL CARCINOMA Tubulocystic carcinoma of the kidney is a recently described tumor entity that was not included in the 2004 WHO classification. The tumors were originally thought to represent low grade collecting duct carcinomas. Recently, a large series of 31 cases have been published. 10 In the published series, 10-12 men have predominated. Follow-up data are limited but only 2 patient have been reported to have had metastasis. The tumors have ranged from 2 to 85 mm in diameter. Tubulocystic carcinoma has a distinctive gross appearance: well circumscribed with an off-white cut spongy surface that shows innumerable cysts filled with clear fluid. The cyst lining is smooth and the cysts are fairly 
PRIMARY RENAL SYNOVIAL SARCOMAS
Synovial sarcoma of the kidney is an entity, which is characterized by a specific morphology and specific cytogenetic characteristics. They consist of spindle cells and frequently have large cysts. Many cases show local recurrence after nephrectomy. Most cases are diagnosed between the ages of 20 and 50 years. [14] [15] [16] Microscopically, tumors are characterized by monomorphic plump spindle cells (Fig. 5 ). The cysts are lined by mitotically inactive epithelial cells without striking cellular atypia (Fig. 6 ). The tumors have been earlier described as embryonal sarcoma of the kidney. There is a slight male predilection (1,6:1) . No bilateral tumors were identified yet. The spindle cells are immunoreactive for EMA, CD56 and sometimes for CD99. They are nonreactive for desmin, actin, S100, and cytokeratins. The cyst epithelium is cytokeratin-positive. Synovial sarcoma is cytogenetically characterized by the translocation t(X;18)(p11.2/q11.2), generating a fusion between the SYT-gene on chromosome 18 and 1 member of the SSX family gene (SSX1;SSX2; SSX4) on chromosome X. Molecularly confirmed primary synovial sarcomas of the kidney have showed the characteristic SYT-SSX gene fusion. In contrast to soft tissue synovial sarcoma in which the SYT-SSX gene fusion is more common than the alternative SYT-SSX2 form, a majority of renal synovial sarcomas have so far exhibited the SYT-SSX2 gene fusion. There is a tendency for a predominance of monophasic spindle morphology of these tumors in the kidney and there are more rarely biphasic tumors. Although prognostic data are limited, there are case reports describing tumors that have responded to chemotherapy. However, recurrence is common.
ACQUIRED CYSTIC DISEASE-ASSOCIATED RENAL CELL CARCINOMA
This recently described RCC is associated with endstage kidneys with acquired cystic disease. 17, 18 Long-term renal dialysis has long been known to predispose to the development of acquired cystic disease and renal cell neoplasms. Many of these appear to be typical clear cell, papillary, and chromophobe renal cell carcinomas. However, morphologically distinctive carcinoma has been discovered in patients with acquired cystic disease. Some appear to be unique to end-stage renal disease and acquired cystic disease. The kidneys are atrophic and have numerous cysts, typical of acquired cystic disease. The carcinomas are usually well circumscribed and the larger ones often have a thick fibrous pseudocapsule that often contains foci of calcification. More than half the tumors appear to arise in a cyst. The architecture is complex with acinar, compact sheets, microscopic, and macroscopic cysts in various combinations (Fig. 7) . Papillary structure ranging from very focal to more than 50% of the tumor, are present in roughly half the tumors. Oxalate crystals are frequent. 19, 20 In the study by Tickoo et al 1 patient died of widespread metastases and 2 other patients had lymph node metastases at the time of nephrectomy.
CLEAR CELL RENAL CELL CARCINOMA WITH PROMINENT CYSTS/MULTILOCULAR CYSTIC RENAL CELL CARCINOMA
In less than 5% of clear cell RCCs, multiple cysts are predominant. Such tumors are well circumscribed, with noncommunicating cysts separated by irregular, thick fibrous septa, reminiscent of a multilocular cyst. These so called cystic or multilocular cystic RCCs are considered a subtype of clear cell RCC. The lining epithelium of the cysts is often attenuated or even absent, but the structures do not represent cystic degeneration of a clear cell RCC of the usual type. 21 Multilocular cystic RCCs are distinguished from multilocular cysts by the present of nodular aggregates of clear cells, in at least some portion of the cyst wall (Fig. 8 ). The identification of small aggregates of low-grade clear cells in the wall of the cysts is important for the correct diagnosis. If a stringent definition of multilocular cystic RCCs is applied, malignant behavior of these tumors has not been reported. Multilocular cystic RCCs must be distinguished from RCCs with cystic changes. The latter have expansile clear cell masses in their cyst walls.
THE FUNCTION OF THE VHL PROTEIN IN RENAL CANCER: A NEW PROGRESSION MODEL FOR VHL-ASSOCIATED RCC THROUGH CYST-DEPENDENT AND CYST-INDEPENDENT PATHWAYS
Between 24 to 45% of VHL patients develop clear cell renal cell carcinoma (ccRCC). 22 Inactivating germline mutations of the VHL gene represents the genetic hallmark of this syndrome and have been shown in almost all VHL patients. 23 Sporadic clear cell RCC is characterized by inactivation of the VHL gene by deletion, mutation or promoter hypermethylation in about 70% of the tumors.
The functions of the VHL protein (pVHL) have been extensively studied in the last 15 years. The VHL protein (pVHL) is implicated in cell-cycle control and gene regulation, and requires transcription-dependent nuclearcytoplasmic trafficking for its function. There are two biologically active VHL protein isoforms: pVHL (30) and pVHL (19) . The distribution of VHL protein isoforms varies in the nuclear and cytoplasmic compartments of renal tumors and alteration of subcellular pVHL trafficking is of potential relevance for the biologic behavior of clearcell RCC. 24 The pVHL functions as a recognition subunit in a E3 ubiquitin protein ligase complex, targeting the hypoxiainducible transcription factor a (HIF-a) for ubiquitinmediated degradation in the presence of oxygen. Loss of VHL function causes accumulation of HIF-1 subunits in the cytoplasm and their translocation to the nucleus. Loss of VHL function results in strongly enhanced transcription of HIF-a inducible genes, especially in upregulation of CXCR4. 25 Therefore, the von Hippel-Lindau (VHL) tumor suppressor gene product is one of the major regulators of CXCR4 expression and increased CXCR4 expression levels are most likely a consequence of impaired VHL function in ccRCC.
Other pVHL functions include fibronectin matrix assembly, p53 stabilization and transactivation. 26 In addition, pVHL has the ability to bind and stabilize microtubules by protecting them from depolymerization, which is a prerequisite for cilium formation. Recent evidence highlights a key role for pVHL in the maintenance of the structure of the primary cilium, a microtubule-based cellular sensory organ that inhibits uncontrolled epithelial cell proliferation and cyst formation in the kidney. In fact, 2 earlier in vitro studies showed that by reexpressing pVHL in VHL null ccRCC cell lines pVHL regulates the formation of primary cilia. These observations strongly suggest that loss of VHL function in renal epithelial cells leads to degeneration of primary cilia, which represents a critical step toward cyst formation and ccRCC development in VHL patients. [27] [28] [29] Interestingly, renal cysts are present in about 60% of individuals suffering from the von Hippel-Lindau (VHL) disease.
One might hypothesize that cyst formation is one of the first visible renal alterations in VHL-caused tumor formation. The formation of kidney cysts is a clinical feature of the VHL cancer syndrome and, in at least some cases, is considered a precursor lesion of clear cell RCC. VHL inactivation might be the driving force for the development of kidney cysts that arise in patients with inherited VHL mutations. These new findings draw attention to a primary cilium maintenance network as a new territory for pVHL tumor suppressive activity and have implications for understanding the development of kidney pathology in the setting of VHL disease. On the basis of these findings, a new progression model for VHL-associated CC RCC through cystdependent and cyst-independent pathways has been proposed ( Fig. 9 ). 30, 31 
